The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment
Open accessAbstract
Previous antiresorptive (AR) treatment may influence the response to teriparatide. We examined BMD response and safety in a subgroup of 503 postmenopausal women with osteoporosis who received teriparatide for 24 mo. Patients were divided into three groups based on their prior AR treatment: treatment-naïve (n = 84); pretreated with no evidence of inadequate treatment response (n = 134); and pretreated showing an inadequate response to AR treatment (n = 285), which was predefined based on the occurrence of fractures, persistent low BMD, and/or significant BMD loss while on therapy. Changes in BMD from baseline were analyzed using mixed model repeated measures. Lumbar spine BMD increased significantly from baseline at 6, 12, 18, and 24 mo in all three groups. The mean gain in spine BMD over 24 mo was greater in the treatment-naïve group (0.095 g/cm2; 13.1%) than in the AR pretreated (0.074 g/cm2; 10.2%; p < 0.005) and inadequate AR responder (0.071 g/cm2; 9.8%; p < 0.001) groups. The corresponding increases in total hip BMD were 3.8%, 2.3%, and 2.3%, respectively. Early decreases in hip BMD in the inadequate AR responder group were reversed by 18 mo of treatment. Increases in BMD between 18 and 24 mo were highly significant. Nausea (13.3%) and arthralgia (11.7%) were the most commonly reported adverse events. Asymptomatic hypercalcemia was reported in 5.0% of patients. Teriparatide treatment for 24 mo is associated with a significant increase in BMD in patients with and without previous AR use. Prior AR treatment modestly blunted the BMD response to teriparatide. Safety was consistent with current prescribing label information.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis
Finkelstein, J. S., Hayes, A., Hunzelman, J. L., Wyland, J. J., Lee, H., & Neer, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035725 · Cited by 829
Orwoll, E., Scheele, W., Paul, S., Adami, S., Syversen, U., Diez-Perez, A., Kaufman, J.-M., Clancy, A., & Gaich, G. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.1.9 · Cited by 776
Lindsay, R., Nieves, J., Formica, C., Henneman, E., Woelfert, L., Shen, V., Dempster, D., & Cosman, F. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02342-8 · Cited by 749
Hodsman, A. B., Bauer, D. C., Dempster, D. W., Dian, L., Hanley, D. A., Harris, S. T., Kendler, D. L., McClung, M. R., Miller, P. D., Olszynski, W. P., et al. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0006 · Cited by 718
Dempster, D. W., Cosman, F., Kurland, E. S., Zhou, H., Nieves, J., Woelfert, L., Shane, E., Plavetić, K., Müller, R., Bilezikian, J., et al. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.10.1846 · Cited by 653
Jiang, Y., Zhao, J. J., Mitlak, B. H., Wang, O., Genant, H. K., & Eriksen, E. F. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.11.1932 · Cited by 616
Genant, H. K., Grampp, S., Glüer, C. C., Faulkner, K. G., Jergas, M., Engelke, K., Hagiwara, S., & van Kuijk, C. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650091002 · Cited by 610
Differential Effects of Teriparatide on BMD After Treatment With Raloxifene or Alendronate
Ettinger, B., Martin, S. J., Crans, G., & Pavo, I. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040117 · Cited by 487
Burr, D. B., Hirano, T., Turner, C. H., Hotchkiss, C., Brommage, R., & Hock, J. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.1.157 · Cited by 295
Keaveny, T. M., Donley, D. W., Hoffmann, P. F., Mitlak, B. H., Glass, E. V., & San Martin, J. A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061011 · Cited by 258
Daily and Cyclic Parathyroid Hormone in Women Receiving Alendronate
Cosman, F., Nieves, J., Zion, M., Woelfert, L., Luckey, M., & Lindsay, R. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050157 · Cited by 250
Lindsay, R., Zhou, H., Cosman, F., Nieves, J., Dempster, D. W., & Hodsman, A. B. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070104 · Cited by 233
Deal, C., Omizo, M., Schwartz, E. N., Eriksen, E. F., Cantor, P., Wang, J., Glass, E. V., Myers, S. L., & Krege, J. H. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050714 · Cited by 223
Hanson, J. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.8.1316 · Cited by 163
Skeletal actions of intermittent parathyroid hormone: Effects on bone remodelling and structure
Compston, J. E. (2007) · Bone · doi:10.1016/j.bone.2006.09.008 · Cited by 160
Graeff, C., Timm, W., Nickelsen, T. N., Farrerons, J., Marín, F., Barker, C., & Glüer, C. C. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070603 · Cited by 159
Self-citationSato, M., Westmore, M. S., Ma, Y. L., Schmidt, A., Zeng, Q. Q., Glass, E. V., Vahle, J. L., Brommage, R., Jerome, C. P., & Turner, C. H. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040112 · Cited by 153
Parathyroid Hormone and Periosteal Bone Expansion
PARFITT, A. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.10.1741 · Cited by 146
Tashjian, A. H., & Chabner, B. A. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.7.1151 · Cited by 146
Effects of Teriparatide, Alendronate, or Both on Bone Turnover in Osteoporotic Men
Finkelstein, J. S., Leder, B. Z., Burnett‐Bowie, S. M., Wyland, J. J., Lee, H., de la Paz, A. V., Gibson, K. L., & Neer, R. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0190 · Cited by 138
Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?
Seeman, E. (2007) · Bone · doi:10.1016/j.bone.2007.06.010 · Cited by 124
Development of an algorithm for using PINP to monitor treatment of patients with teriparatide
Eastell, R., Krege, J. H., Chen, P., Glass, E. V., & Reginster, J. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x75096 · Cited by 122
Nonresponders to Osteoporosis Therapy
Lewiecki, E. M. (2003) · Journal of Clinical Densitometry · doi:10.1385/jcd:6:4:307 · Cited by 104
Ma, Y. L., Bryant, H. U., Zeng, Q., Schmidt, A., Hoover, J. L., Cole, H. W., Yao, W., Jee, W. S. S., & Sato, M. (2003) · Endocrinology · doi:10.1210/en.2002-221061 · Cited by 91
Arnaud, C. D., Roe, E. B., Sanchez, S., del Puerto, G. A., Pierni, E., Bachetti, P., & Cann, C. F. (2000) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(00)82061-5 · Cited by 68
Leslie, W. D., DeVos, G., Dupont, J. O., & Peterdy, A. E. (2001) · Journal of Clinical Densitometry · doi:10.1385/jcd:4:4:307 · Cited by 9
Cited by
The clinician's guide to prevention and treatment of osteoporosis
LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022) · Osteoporosis International · doi:10.1007/s00198-021-05900-y · Cited by 1,487
Leder, B. Z., Tsai, J. N., Uihlein, A. V., Wallace, P. M., Lee, H., Neer, R. M., & Burnett-Bowie, S.-A. M. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61120-5 · Cited by 603
Kendler, D. L., Marin, F., Zerbini, C. A. F., Russo, L. A., Greenspan, S. L., Zikan, V., Bagur, A., Malouf-Sierra, J., Lakatos, P., Fahrleitner-Pammer, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32137-2 · Cited by 598
Self-citationLangdahl, B. L., Libanati, C., Crittenden, D. B., Bolognese, M. A., Brown, J. P., Daizadeh, N. S., Dokoupilova, E., Engelke, K., Finkelstein, J. S., Genant, H. K., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31613-6 · Cited by 497
Guidelines for the management of osteoporosis and fragility fractures
Nuti, R., Brandi, M. L., Checchia, G., Di Munno, O., Dominguez, L., Falaschi, P., Fiore, C. E., Iolascon, G., Maggi, S., Michieli, R., et al. (2019) · Internal and Emergency Medicine · doi:10.1007/s11739-018-1874-2 · Cited by 328
Metadata
- Authors
- Obermayer-Pietsch, B. M., Marin, F., McCloskey, E. V., Hadji, P., Farrerons, J., Boonen, S., Audran, M., Barker, C., Anastasilakis, A. D., Fraser, W. D., & Nickelsen, T.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-10-01
- Volume
- 23
- Issue
- 10
- Pages
- 1591-1600
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2096303371
- Cited by
- 290
- References
- 28
- FWCI
- 14.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.